|
Report Date : |
09.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
ZAO VERTEKS |
|
|
|
|
Registered Office : |
Ul Tipanova d 8,
kv 100, 196135 g Sankt-Peterburg |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
07.12.1999 |
|
|
|
|
Com. Reg. No.: |
1037821026484 |
|
|
|
|
Legal Form : |
Closed and joint-stock companies |
|
|
|
|
Line of Business : |
Manufacture of basic pharmaceutical products |
|
|
|
|
No. of Employees |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
|
A2 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
RUZSSIA ECONOMIC OVERVIEW
|
Source
: CIA |
ZAO
"VERTEKS"
ul Tipanova d 8, kv 100,
196135 g Sankt-Peterburg
Tel: 78002000305
Telefax: 78123293041
E-Mail: vertex@vertex.spb.ru
Web: www.vertex.spb.ru
|
Legal form |
Closed and joint-stock companies (ZAO) |
|
|
Established on |
07/12/1999 - Closed and joint-stock companies (ZAO) |
|
Registered on |
04/02/2003, INSPEKTSIYA
MNS ROSSII PO MOSKOVSKOMU RAYONU SANKT-PETERBURGA, RegNr.:
1037821026484 |
|
Registered capital |
|
RUB |
10 500,- |
|
|
Stockholders |
Rossii Grazhdane |
% |
100 |
|
|
Sole Executive Body |
GEORGIY EDUARDOVICH
POBELYANSKIY |
|
General data |
Main activity: |
|
|
|
Full name: |
|
|
Name in foreign
language: |
|
|
Short name: |
|
|
|
|
|
Residence address: |
|
|
Permanent address: |
|
|
The main activity of ZAO “VERTEKS” is production of pharmaceutical products under the brands “ASPIKOR”, “GINOKOMFORT”, “MON AMI”, “ALERANA, “NORMAVEN”, “REDERM”, etc. |
Other activities
|
|
|
: |
|
|
|
Manufacture of pharmaceutical preparations |
(24.42) |
|
|
Manufacture of pharmaceutical preparations |
(24.42.1) |
|
|
Manufacture of pharmaceutical preparations |
(24.42.2) |
|
|
Manufacture of perfumes and toilet preparations |
(24.52) |
|
|
Agents specializing in the sale of particular products or ranges of products n.e.c. |
(51.18.1) |
|
|
Wholesale of perfume and cosmetics |
(51.45.1) |
|
|
Wholesale of pharmaceutical goods |
(51.46.1) |
|
|
Letting of own property |
(70.2) |
|
|
Research and experimental development on natural sciences and engineering |
(73.10) |
|
|
Business and management consultancy activities |
(74.14) |
|
|
Technical testing and analysis |
(74.30.1) |
|
|
Technical testing and analysis |
(74.30.3) |
|
Annual turnover |
31/12/2007 |
Enterprise turnover |
RUB |
533 163 000,- |
|
|
|
31/12/2008 |
Enterprise turnover |
RUB |
811 021 000,- |
|
|
|
31/12/2009 |
Enterprise turnover |
RUB |
1 232 036 000,- |
|
|
|
31/12/2010 |
Enterprise turnover |
RUB |
1 904 218 000,- |
|
|
|
31/12/2011 |
Enterprise turnover |
RUB |
2 105 158 000,- |
|
|
|
31/12/2012 |
Enterprise turnover |
RUB |
2 407 702 000,- |
|
|
|
31/12/2013 |
Enterprise turnover |
RUB |
2 339 970 000,- |
|
|
Events, negative data |
27.04.2012 - Legal debt
collection procedure |
|
Remarks |
ZAO “VERTEKS” has
following licenses: |
|
A. The enclosed balance
of 2011 is originated from official source, no data available about authentication.
(31.12.2011 - 1000 RUB) - Warning! The figures stated in the balance sheet
may contain error(s). |
|
balance |
A 31.12.2011 |
B 31.12.2012 |
C 31.12.2013 |
|
1. ASSETS |
|
|
|
|
I. FIXED ASSETS |
|
|
|
|
Intangible assets |
5 050 |
5 500 |
8 308 |
|
The results of research and development |
3 154 |
9 755 |
20 874 |
|
Intangible research assets |
0 |
0 |
0 |
|
Tangible research assets |
0 |
0 |
0 |
|
Fixed assets |
139 335 |
198 477 |
172 852 |
|
Profitable investments in tangible assets |
0 |
0 |
0 |
|
Financial investments |
0 |
0 |
0 |
|
Deferred tax assets |
12 696 |
15 478 |
14 176 |
|
Other non-current assets |
95 284 |
224 138 |
624 074 |
|
TOTAL IN SECTION I. |
255 519 |
453 348 |
840 284 |
|
II. CURRENT ASSETS |
|
|
|
|
Inventories |
368 591 |
364 533 |
399 344 |
|
VAT on acquired assets |
12 625 |
21 464 |
14 929 |
|
Accounts receivable |
744 977 |
920 698 |
1 013 745 |
|
Financial investments (excluding the monetary equivalent) |
0 |
0 |
66 280 |
|
Cash and monetary equivalents |
147 435 |
126 031 |
10 445 |
|
Other current assets |
3 195 |
3 056 |
19 920 |
|
TOTAL IN SECTION II. |
1 276 823 |
1 435 781 |
1 524 663 |
|
BALANCE |
1 532 342 |
1 889 129 |
2 364 947 |
|
2. LIABILITIES |
|
|
|
|
III. CAPITAL AND RESERVES |
|
|
|
|
Authorized capital (share capital, charter capital, deposits capital, partners capital) |
11 |
11 |
11 |
|
Treasury stock |
0 |
0 |
0 |
|
Revaluation of fixed assets |
0 |
0 |
0 |
|
Additional capital (without revaluation) |
49 998 |
49 998 |
49 998 |
|
Reserve capital |
2 |
2 |
2 |
|
Retained earnings (uncovered loss) |
866 340 |
1 152 562 |
1 320 092 |
|
TOTAL IN SECTION III. |
916 351 |
1 202 573 |
1 370 103 |
|
IV. LONG-TERM LIABILITIES |
|
|
|
|
Borrowed funds |
368 609 |
270 590 |
599 790 |
|
Deferred tax liabilities |
14 105 |
20 632 |
39 441 |
|
Provisions |
0 |
0 |
0 |
|
Other liabilities |
0 |
0 |
0 |
|
TOTAL IN SECTION IV. |
382 714 |
291 221 |
639 231 |
|
V. SHORT-TERM LIABILITIES |
|
|
|
|
Borrowed funds |
268 |
1 033 |
21 678 |
|
Payables |
222 267 |
383 777 |
316 817 |
|
Deferred income |
0 |
0 |
0 |
|
Provisions |
10 742 |
10 525 |
17 118 |
|
Sonstige Verbindlichkeiten |
0 |
0 |
0 |
|
TOTAL IN SECTION V. |
233 277 |
395 335 |
355 613 |
|
BALANCE |
1 532 342 |
1 889 129 |
2 364 947 |
|
A. The enclosed profit
and loss account of 2011 is originated from official source, no data available
about authentication. (31.12.2011 - 1000 RUB) |
|
profit and loss
account |
A 31.12.2011 |
B 31.12.2012 |
C 31.12.2013 |
|
Turnover |
2 105 158 |
2 407 702 |
2 339 970 |
|
Cost of sales |
502 348 |
674 103 |
641 726 |
|
Gross profit (loss) |
1 602 810 |
1 733 599 |
1 698 244 |
|
Selling expenses |
430 058 |
437 119 |
488 572 |
|
Administrative expenses |
262 570 |
309 291 |
347 337 |
|
Sales profit (loss) |
910 182 |
987 189 |
862 335 |
|
Earnings from other entities |
0 |
0 |
0 |
|
Interest receivable |
7 269 |
15 543 |
3 656 |
|
Interest payable |
26 119 |
26 591 |
29 892 |
|
Other operating income |
380 308 |
496 827 |
492 026 |
|
Other operating expenses |
875 102 |
1 104 989 |
1 110 518 |
|
Profit (loss) before tax |
396 538 |
367 979 |
217 607 |
|
Current profit tax |
79 384 |
75 506 |
29 631 |
|
Permanent tax liabilities (assets) |
-5 085 |
-5 193 |
5 426 |
|
Change in deferred tax liabilities |
14 105 |
6 526 |
18 811 |
|
Change in deferred tax assets |
9 096 |
2 782 |
-1 302 |
|
Different |
36 |
2 505 |
333 |
|
Net profit (loss) |
312 109 |
286 224 |
167 530 |
|
Results of fixed assets revaluation, non-includedin net profit/loss for period |
0 |
0 |
0 |
|
Result of other transactions, non included in net profit/loss for period |
0 |
0 |
0 |
|
Total financial result for period |
312 109 |
286 224 |
167 530 |
|
Ratios |
|
2011 |
2012 |
2013 |
|
|
Quick ratio |
4,01 |
2,72 |
3,22 |
|
|
Current ratio |
2,33 |
1,28 |
1,47 |
|
|
Average Collection Period |
64,58 |
126 |
151 |
|
|
Payables turnover Period |
80,75 |
164 |
199 |
|
|
Debt ratio |
0,4 |
0,36 |
0,42 |
|
|
Equity to total assets ratio |
0,6 |
0,64 |
0,58 |
|
|
Funding ratio |
1,51 |
1,78 |
1,4 |
|
|
Return on sales |
14,83 |
11,89 |
7,16 |
|
|
Return on Assets |
27,11 |
20,06 |
10,31 |
|
|
Return on Equity |
n/a |
27,02 |
13,02 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.26 |
|
|
1 |
Rs.97.51 |
|
Euro |
1 |
Rs.77.94 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.